Sangamo Biosciences, Inc. (NASDAQ:SGMO), a leader in therapeutic genome editing, announced unanimous approval by the National Institutes of Health’s Recombinant DNA Advisory Committee …
In a research report released Friday, Cowen’s healthcare analyst Ritu Baral shed some light on Sangamo Biosciences, Inc. (NASDAQ:SGMO), after the company announced a restructuring of …
Yesterday, Sangamo Biosciences, Inc. (NASDAQ:SGMO) announced it will be restructuring its collaboration with Shire PLC (ADR) (NASDAQ:SHPG) in order to speed up the …
In a research report published Wednesday, J.P.
Wedbush analyst Liana Moussatos weighed in today with a few insights on Sangamo Biosciences, Inc. (NASDAQ:SGMO), after the company announced that it has regained the rights …
Sangamo BioSciences, Inc. (NASDAQ:SGMO), a leader in therapeutic genome editing, announced today that the company and its collaborator, Shire PLC (ADR) (NASDAQ:SHPG), have agreed …
Sangamo Biosciences, Inc. (NASDAQ:SGMO) reported its second quarter 2015 financial results and accomplishments.
Four men taking part in an illegal insider trading scheme between California, New Jersey, and Florida have been arrested and charged after earning …
